Johnson John
Xeris Biopharma Holdings, Inc. ยท Director
Johnson John is listed in public filings as director. This Johnson John insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Xeris Biopharma Holdings, Inc. (XERS), Verastem, Inc. (VSTM), AxoGen, Inc. (AXGN), and Applied Therapeutics, Inc. (APLT). Investors use Johnson John's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $203k33k shares | Grant / ExerciseJun 4, 2026 | $202.9K33k shares | $6.15 | -- | |
| --707.3k shares | Grant / ExerciseJun 4, 2026 | Disclosure amount unavailable24.2k shares | -- | -- | |
| $4.2M683.1k shares | SellJun 4, 2026 | $91.4K15k shares | $6.09 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --52.7k shares | Grant / ExerciseMay 21, 2026 | Disclosure amount unavailable36k shares | -- | -- | |
| $011.1k shares | SellMay 7, 2026 | $478.0K11.1k shares | $43.26 | -- | |
| $011.1k shares | Grant / ExerciseMay 7, 2026 | $77.8K11.1k shares | $7.04 | -- | |
| $5.0M698.1k shares | SellDec 19, 2025 | $977.0K135.4k shares | $7.22 | -- | |
| $013.1k shares | SellDec 9, 2025 | $394.0K13.1k shares | $29.98 | -- | |
| $394k13.1k shares | SellDec 9, 2025 | $256.2K8.5k shares | $29.98 | -- | |
| $08.5k shares | Grant / ExerciseDec 9, 2025 | $53.8K8.5k shares | $6.30 | -- | |
| $410k13.1k shares | SellDec 8, 2025 | $371.3K11.9k shares | $31.22 | -- | |
| $411k13.1k shares | SellDec 8, 2025 | $368.9K11.8k shares | $31.26 | -- | |
| $54k8.5k shares | Grant / ExerciseDec 8, 2025 | $74.9K11.9k shares | $6.30 | -- | |
| $6.1M833.5k shares | SellAug 13, 2025 | $786.5K107.5k shares | $7.32 | -- | |
| --14.2k shares | Grant / ExerciseJun 19, 2025 | Disclosure amount unavailable14.2k shares | -- | -- | |
| $265k24.9k shares | SellJun 9, 2025 | $43.2K4.1k shares | $10.61 | -- | |
| --941k shares | Grant / ExerciseJun 4, 2025 | Disclosure amount unavailable50k shares | -- | -- | |
| --16.7k shares | Grant / ExerciseMay 22, 2025 | Disclosure amount unavailable8.3k shares | -- | -- | |
| $94k12.5k shares | Grant / ExerciseMay 22, 2025 | $93.5K12.5k shares | $7.48 | -- | |
| $1.0M1M shares | Grant / ExerciseDec 19, 2024 | $1.0M1M shares | $1.02 | -- | |
| --500k shares | Grant / ExerciseDec 19, 2024 | Disclosure amount unavailable500k shares | -- | -- | |
| --11.9k shares | Grant / ExerciseSep 1, 2024 | Disclosure amount unavailable11.9k shares | -- | -- | |
| --8.3k shares | Grant / ExerciseJun 18, 2024 | Disclosure amount unavailable8.3k shares | -- | -- | |
| $41k12.5k shares | Grant / ExerciseJun 18, 2024 | $40.9K12.5k shares | $3.27 | -- |